ArticleScientific reports2024

Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas.

Janet L Oblinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.